Author Voors, Adriaan A.
-
2006 | Journal Article
Rationale and design of a study to evaluate management of proteinuria in patients at high risk for vascular events: the IMPROVE trial
Bakris, G. L.; Ruilope, L.; Locatelli, F.; Ptaszynska, A.; Pieske, B. M.; Raz, I. & Voors, A. A. et al. (2006)
Journal of Human Hypertension, 20(9) pp. 693-700. DOI: https://doi.org/10.1038/sj.jhh.1002050
Details DOI PMID PMC WoS
-
2015 | Journal Article
Rationale and design of MinerAlocorticoid Receptor antagonist Tolerability Study-Heart Failure (ARTS-HF): a randomized study of finerenone vs. eplerenone in patients who have worsening chronic heart failure with diabetes and/or chronic kidney disease
Pitt, B.; Anker, S.-D.; Boehm, M.; Gheorghiade, M.; Kober, L.; Krum, H. & Maggioni, A. P. et al. (2015)
European Journal of Heart Failure, 17(2) pp. 224-232. DOI: https://doi.org/10.1002/ejhf.218
Details DOI PMID PMC WoS
-
2015 | Journal Article
Comparative Assessment of Short-Term Adverse Events in Acute Heart Failure With Cystatin C and Other Estimates of Renal Function: Results From the ASCEND-HF Trial
Tang, W. H. W.; Dupont, M.; Hernandez, A. F.; Voors, A. A.; Hsu, A. P.; Felker, G. M. & Butler, J. et al. (2015)
JACC Heart Failure, 3(1) pp. 40-49. DOI: https://doi.org/10.1016/j.jchf.2014.06.014
Details DOI PMID PMC WoS
-
2016 | Journal Article | Erratum
Erratum to “Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency” [Eur J Heart Fail 2016;18:482-489]
Anker, S. D. ; Schroeder, S.; Atar, D.; Bax, J. J.; Ceconi, C.; Cowie, M. R. & Crisp, A. et al. (2016)
European Journal of Heart Failure, 18(6) pp. 727-727. DOI: https://doi.org/10.1002/ejhf.591
Details DOI
-
2016 | Journal Article
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P.; Voors, A. A.; Anker, S. D. ; Bueno, H.; Cleland, J. G. F.; Coats, A. J. S. & Falk, V. et al. (2016)
European Journal of Heart Failure, 18(8) pp. 891-975. DOI: https://doi.org/10.1002/ejhf.592
Details DOI
-
2016 | Journal Article
A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: rationale, design, and baseline characteristics of BIOSTAT-CHF
Voors, A. A.; Anker, S. D. ; Cleland, J. G.; Dickstein, K.; Filippatos, G.; van der Harst, P. & Hillege, H. L. et al. (2016)
European Journal of Heart Failure, 18(6) pp. 716-726. DOI: https://doi.org/10.1002/ejhf.531
Details DOI
-
2016 | Review |
Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency
Anker, S.-D.; Schroeder, S.; Atar, D.; Bax, J. J.; Ceconi, C.; Cowie, M. R.& AdamCrisp, A. et al. (2016)
European Journal of Heart Failure, 18(5) pp. 482-489.
Wiley-blackwell. DOI: https://doi.org/10.1002/ejhf.516
Details DOI PMID PMC WoS
-
2016 | Journal Article |
A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease
Filippatos, G. S.; Anker, S.-D.; Boehm, M.; Gheorghiade, M.; Kober, L.; Krum, H. & Maggioni, A. P. et al. (2016)
European Heart Journal, 37(27) pp. 2105-2114. DOI: https://doi.org/10.1093/eurheartj/ehw132
Details DOI PMID PMC WoS
-
2017 | Journal Article
Development and validation of multivariable models to predict mortality and hospitalization in patients with heart failure
Voors, A. A.; Ouwerkerk, W.; Zannad, F.; van Veldhuisen, D. J.; Samani, N. J.; Ponikowski, P. & Ng, L. L. et al. (2017)
European Journal of Heart Failure, 19(5) pp. 627-634. DOI: https://doi.org/10.1002/ejhf.785
Details DOI
-
2017 | Journal Article
The PCSK9-LDL Receptor Axis and Outcomes in Heart Failure
Bayes-Genis, A.; Núñez, J.; Zannad, F.; Ferreira, J. P.; Anker, S. D. ; Cleland, J. G. & Dickstein, K. et al. (2017)
Journal of the American College of Cardiology, 70(17) pp. 2128-2136. DOI: https://doi.org/10.1016/j.jacc.2017.08.057
Details DOI